Lawrence Bruno Acquires 5,000 Shares of Core Laboratories (NYSE:CLB) Stock

Core Laboratories Inc. (NYSE:CLB) CEO Lawrence Bruno purchased 5,000 shares of the firm’s stock in a transaction on Friday, July 31st. The shares were acquired at an average price of $10.78 per share, for a total transaction of $53,900.00. Following the purchase, the chief executive officer directly owned 262,438 shares of the company’s stock, valued at approximately $2,829,081.64. This represents a 1.94% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Core Laboratories Trading Down 2.6%

Shares of Core Laboratories stock opened at $10.93 on Thursday. Core Laboratories Inc. has a 52-week low of $9.72 and a 52-week high of $20.36. The firm has a market capitalization of $501.42 million, a PE ratio of 19.52, a price-to-earnings-growth ratio of 2.71 and a beta of 1.03. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.12 and a quick ratio of 1.55. The company’s fifty day moving average price is $11.82 and its two-hundred day moving average price is $15.03.

Core Laboratories (NYSE:CLB) last released its quarterly earnings data on Wednesday, July 29th. The oil and gas company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. The company had revenue of $124.61 million during the quarter, compared to the consensus estimate of $126.26 million. Core Laboratories had a net margin of 5.10% and a return on equity of 10.03%. The firm’s revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period last year, the firm earned $0.19 EPS. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. On average, analysts expect that Core Laboratories Inc. will post 0.53 EPS for the current year.

Core Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Monday, August 10th will be issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, August 10th. Core Laboratories’s payout ratio is presently 7.14%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in CLB. Heartland Advisors Inc. bought a new stake in shares of Core Laboratories during the first quarter worth approximately $2,518,000. UBS Group AG lifted its holdings in Core Laboratories by 32.9% in the fourth quarter. UBS Group AG now owns 412,515 shares of the oil and gas company’s stock valued at $6,613,000 after buying an additional 102,151 shares during the period. Hantz Financial Services Inc. boosted its stake in Core Laboratories by 124.7% in the fourth quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock valued at $51,000 after acquiring an additional 1,763 shares during the last quarter. Abacus Wealth Partners LLC bought a new position in Core Laboratories in the fourth quarter valued at approximately $233,000. Finally, Argos Wealth Advisors LLC acquired a new stake in Core Laboratories during the 4th quarter worth $258,000. 97.81% of the stock is owned by institutional investors.

Analysts Set New Price Targets

CLB has been the topic of several recent analyst reports. Weiss Ratings raised Core Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday. Wall Street Zen upgraded Core Laboratories from a “sell” rating to a “hold” rating in a research note on Saturday, August 1st. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, Core Laboratories currently has a consensus rating of “Hold”.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.